Ocular pseudoexfoliation syndrome and vascular disease: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Wang, Wei ^a   He, Miao ^a   Zhou, Minwen ^a   Zhang, Xiulan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AORTA ANEURYSM; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIFESTYLE; PSEUDOEXFOLIATION; RACE DIFFERENCE; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VASCULAR DISEASE; BIOLOGICAL MODEL; COMPARATIVE STUDY; COMPLICATION; EXFOLIATION SYNDROME; FEMALE; MALE; META ANALYSIS; RISK FACTOR; VASCULAR DISEASES;

EXFOLIATION SYNDROME; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; RISK FACTORS; VASCULAR DISEASES;

EID: 84899831147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092767     Document Type: Review

References (33)

1. Ritch R, Schlotzer-Schrehardt U (2001) Exfoliation syndrome. Surv Ophthalmol 45: 265-315. (Pubitemid 32146432)
2. You QS, Xu L, Wang YX, Yang H, Ma K, et al. (2013) Pseudoexfoliation: normative data and associations: the beijing eye study 2011. Ophthalmology 120: 1551-1558.
3. Tarkkanen A (2008) Is exfoliation syndrome a sign of systemic vascular disease? Acta Ophthalmol 86: 832-836.
4. Yokusoglu M (2012) Is pseudoexfoliation syndrome a risk factor for cardiovascular diseases? Anadolu Kardiyoloji Dergisi 12: 488-489.
5. Katsi V, Pavlidis AN, Kallistratos MS, Fitsios A, Bratsas A, et al. (2013) Cardiovascular Repercussions of the Pseudoexfoliation Syndrome. N Am J Med Sci 5: 454-459.
6. Kocabeyoglu S, Mocan MC, Irkec M, Pinar A, Bozkurt B, et al. (2013) Serum vitamin D deficiency and its association with systemic disease in exfoliation syndrome. Eur J Ophthalmol: 0.
7. Gonen KA, Gonen T, Gumus B (2013) Renal artery stenosis and abdominal aorta aneurysm in patients with pseudoexfoliation syndrome. Eye (Basingstoke) 27: 735-741.
8. French DD, Margo CE, Harman LE (2012) Ocular pseudoexfoliation and cardiovascular disease: A national cross-section comparison study. North American Journal of Medical Sciences 4: 468-473.
9. Djordjevic-Jocic J, Jovanovic P, Bozic M, Tasic A, Rancic Z (2012) Prevalence and early detection of abdominal aortic aneurysm in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Curr Eye Res 37: 617-623.
10. Praveen MR, Shah SK, Vasavada AR, Diwan RP, Shah SM, et al. (2011) Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study. Eye (Lond) 25: 174-179.
11. Andrikopoulos GK, Mela EK, Georgakopoulos CD, Papadopoulos GE, Damelou AN, et al. (2009) Pseudoexfoliation syndrome prevalence in Greek patients with cataract and its association to glaucoma and coronary artery disease. Eye (Lond) 23: 442-447.
12. Sekeroglu MA, Bozkurt B, Irkec M, Ustunel S, Orhan M, et al. (2008) Systemic associations and prevalence of exfoliation syndrome in patients scheduled for cataract surgery. Eur J Ophthalmol 18: 551-555.
13. Citirik M, Acaroglu G, Batman C, Yildiran L, Zilelioglu O (2007) A possible link between the pseudoexfoliation syndrome and coronary artery disease. Eye (Lond) 21: 11-15. (Pubitemid 46061863)
14. Ritland JS, Egge K, Lydersen S, Juul R, Semb SO (2004) Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand 82: 401-404. (Pubitemid 39199439)
15. Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124: 685-687. (Pubitemid 27469246)
16. Speckauskas M, Tamosiunas A, Jasinskas V (2012) Association of ocular pseudoexfoliation syndrome with ischaemic heart disease, arterial hypertension and diabetes mellitus. Acta Ophthalmol 90: e470-e475.
17. Viso E, Rodriguez-Ares MT, Gude F (2010) Prevalence of pseudoexfoliation syndrome among adult Spanish in the Salnes eye Study. Ophthalmic Epidemiol 17: 118-124.
18. Emiroglu MY, Coskun E, Karapinar H, Capkin M, Kaya Z, et al. (2010) Is pseudoexfoliation syndrome associated with coronary artery disease? N Am J Med Sci 2: 487-490.
19. Tarkkanen A, Reunanen A, Kivela T (2008) Frequency of systemic vascular diseases in patients with primary open-angle glaucoma and exfoliation glaucoma. Acta Ophthalmol 86: 598-602.
20. Brajkovi Ae J, Others (2007) Ocular pseudoexfoliation syndrome and internal systemic diseases. Acta Clin Croat 46: 57.
21. Konstas AG, Tsatsos I, Kardasopoulos A, Bufidis T, Maskaleris G (1998) Preoperative features of patients with exfoliation glaucoma and primary open-angle glaucoma. The AHEPA study. Acta Ophthalmol Scand 76: 208-212. (Pubitemid 28177212)
22. Elhawy E, Kamthan G, Dong CQ, Danias J (2012) Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations. Hum Genomics 6: 22.
23. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62: 1006-1012.
24. Wells G, Shea B, O'Connell D, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
25. Ulus T, Nadir A, Yaz YA, Ozdemir AO, Mutlu F, et al. (2013) Cardiovascular involvement in patients with pseudoexfoliation syndrome. J Cardiovasc Med (Hagerstown) 14: 587-592.
26. Ulus T, Nadir A, Yaz YA, Ozdemir AO, Mutlu F, et al. (2013) Cardiovascular involvement in patients with pseudoexfoliation syndrome. J Cardiovasc Med (Hagerstown) 14: 587-592.
27. Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, Hollo G, Mitova D, et al. (2004) Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 88: 523-527. (Pubitemid 38437874)
28. Zakrzewski PA, Mackenzie PJ, Tsai G, Warner SJ, Levin A, et al. (2012) Does an association exist between pseudoexfoliation syndrome and chronic kidney disease? J Glaucoma 21: 562-566.
29. Zenkel M, Lewczuk P, Junemann A, Kruse FE, Naumann GO, et al. (2010) Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol 176: 2868-2879.
30. Djordjevic-Jocic J, Zlatanovic G, Veselinovic D, Jovanovic P, Djordjevic V, et al. (2012) Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucoma/syndrome. Vojnosanit Pregl 69: 231-236.
31. Browne JG, Ho SL, Kane R, Oliver N, Clark AF, et al. (2011) Connective Tissue Growth Factor is increased in Pseudoexfoliation Glaucoma. Invest Ophthalmol Vis Sci.
32. Demir N, Ulus T, Yucel OE, Kumral ET, Singar E, et al. (2011) Assessment of myocardial ischaemia using tissue Doppler imaging in pseudoexfoliation syndrome. Eye (Lond) 25: 1177-1180.
33. Yuksel N, Anik Y, Altintas O, Onur I, Caglar Y, et al. (2006) Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma. Ophthalmologica 220: 125-130. (Pubitemid 43289456)